Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Agios Pharmaceuticals revenue
Agios Pharmaceuticals's revenue is $94.4 million.
What is Agios Pharmaceuticals's revenue?
- Agios Pharmaceuticals's revenue growth from 2012 to 2018 is 275.95%.
- Agios Pharmaceuticals has 536 employees, and the revenue per employee ratio is $176,095.
- Agios Pharmaceuticals's peak quarterly revenue was $9.0M in 2024(q3).
- Agios Pharmaceuticals peak revenue was $94.4M in 2018.
- Agios Pharmaceuticals annual revenue for 2017 was 43.0M, -38.46% growth from 2016.
- Agios Pharmaceuticals annual revenue for 2018 was 94.4M, 119.45% growth from 2017.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Agios Pharmaceuticals historical revenue
Agios Pharmaceuticals's peak revenue was $94.4M in 2018. The peak quarterly revenue was $9.0M in 2024(q3).
Agios Pharmaceuticals's revenue increased from $25.1m in 2012 to $94.4M currently. That's a 275.95% change in annual revenue.
Agios Pharmaceuticals annual revenue
Agios Pharmaceuticals annual revenue over time
| Fiscal year / year | Agios Pharmaceuticals revenue |
|---|---|
| 2012 | $25.1M |
| 2013 | $25.5M |
| 2014 | $65.4M |
| 2015 | $59.1M |
| 2016 | $69.9M |
| 2017 | $43.0M |
| 2018 | $94.4M |
How accurately did Agios Pharmaceuticals' revenue projections match actual performance?
Agios Pharmaceuticals annual growth
Agios Pharmaceuticals saw the greatest revenue growth in 2014, when revenue increased by 155.82%.
Agios Pharmaceuticals had the lowest revenue growth in 2022, when revenue changed by -84.91%.
Agios Pharmaceuticals annual growth rate over time
| Year | Agios Pharmaceuticals growth |
|---|---|
| 2013 | 2%↑ |
| 2014 | 156%↑ |
| 2015 | -10%↓ |
| 2016 | 18%↑ |
| 2017 | -38%↓ |
| 2018 | 119%↑ |
Agios Pharmaceuticals jobs nearby
Do you work at Agios Pharmaceuticals?
Did Agios Pharmaceuticals meet its revenue projections?
Agios Pharmaceuticals financial information
| CEO | Jacqualyn Fouse (Jackie) |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 536 |
| Date Founded | 2008 |
| Headquarters | Cambridge, Massachusetts |
| Number of Locations | 1 |
| Revenue | $94.4M |
| Net Income | -$231,801,000 |
| Gross Proft | $93.0M (2018) |
| PE Ratio | 1.95 |
| Tax Rate | 0.0% |
| Market Capitalization | $3.1B |
| Total Assets | $1,238,718,000 |
| Ticker | AGIO |
Agios Pharmaceuticals jobs you might like
Agios Pharmaceuticals financing
Agios Pharmaceuticals received early financing of $33.0M on 2008-07-07.
| Series | Round size | Date |
|---|---|---|
| Series A | $33M | 07/2008 |
| Series B | $8.8M | 04/2010 |
| Series C | $78M | 11/2011 |
Agios Pharmaceuticals investors
| Investors | Security type |
|---|---|
| ARCH Venture Partners | Series A |
| Third Rock Ventures | Series A |
| Flagship Pioneering Inc | Series A |
| CELGENE CORP DE | Series B |
| CELGENE CORP DE | Series C |
| Third Rock Ventures | Series C |
| ARCH Venture Partners | Series C |
| Flagship Pioneering Inc | Series C |
Search for jobs
Agios Pharmaceuticals highest paying jobs
Zippia gives an in-depth look into the details of Agios Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Agios Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Agios Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Agios Pharmaceuticals. The data presented on this page does not represent the view of Agios Pharmaceuticals and its employees or that of Zippia.
Agios Pharmaceuticals may also be known as or be related to AGIOS PHARMACEUTICALS INC, AGIOS PHARMACEUTICALS INC., Agios Pharmaceuticals, Agios Pharmaceuticals Inc and Agios Pharmaceuticals, Inc.